Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Support Care Cancer ; 32(3): 150, 2024 Feb 08.
Article in English | MEDLINE | ID: mdl-38329552

ABSTRACT

PURPOSE: Many patients experience oral adverse events during head and neck cancer radiotherapy (RT). The methods of management of such events are under debate. One such technique is the intraoral stent (IOS) technique, which removes normal tissue from the irradiation field. This retrospective study examined the factors associated with the occurrence of oral mucositis (OM) and dysgeusia and the efficacy of IOSs in preventing them. METHODS: Twenty-nine patients who underwent RT in the maxilla or nasal cavity between 2016 and 2022 were included. They were investigated for background characteristics, treatment factors (IOS and dose-volume histogram), and oral adverse events (OM and dysgeusia). RESULTS: Significant risk factors for the incidence of grade ≥ 2 (Common Terminology Criteria for Adverse Events v5.0) OM were the non-use of IOSs (p = 0.004) and diabetes (p = 0.025). A significant risk factor for the incidence of grade ≥ 1 dysgeusia was concomitant chemotherapy (p = 0.019). The radiation dose to the tongue was significantly lower in the IOS group than in the non-IOS group. CONCLUSION: Our findings suggest that the use of an IOS during RT reduces the severity of OM by reducing irradiation to the tongue. Therefore, the use of an IOS is recommended during RT performed in the maxilla or nasal cavity.


Subject(s)
Neoplasms , Stomatitis , Humans , Maxilla , Dysgeusia/epidemiology , Dysgeusia/etiology , Dysgeusia/prevention & control , Nasal Cavity , Retrospective Studies , Stents , Stomatitis/epidemiology , Stomatitis/etiology , Stomatitis/prevention & control
2.
Cancer Radiother ; 25(5): 507-513, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33685809

ABSTRACT

Purpose of this review of medical literature is to present the immediate side effects of radiation therapy for head and neck cancer and their treatment. The likelihood and severity of these immediate side effects depends on a number of factors, including the total dose of radiation delivered, over what time it was delivered and what parts of the head and neck received radiation. Early side effects include: inflammation of the oropharyngeal mucosa (mucositis), painful swallowing (odynophagia), difficulty swallowing (dysphagia), hoarseness, lack of saliva (xerostomia), orofacial pain, laryngeal radionecrosis, dermatitis, hair loss, nausea, vomiting, inadequate nutrition and hydration, and weight loss. These complications can interfere with, and delay treatment. Most of these side effects generally dissipate over time. In conclusion, radiation treatment for the head and neck cancer causes significant early side effects. Many of these side effects present difficult challenges to the patients. Their recognition and treatment can significantly improve the patients' health, long-term survival and quality of life. The review provides information that can assist head and cancer survivors deal with radiation side effects.


Subject(s)
Head and Neck Neoplasms/radiotherapy , Radiotherapy/adverse effects , Alopecia/etiology , Brain/radiation effects , Deglutition Disorders/etiology , Deglutition Disorders/prevention & control , Dehydration/etiology , Dehydration/prevention & control , Dysgeusia/etiology , Dysgeusia/prevention & control , Facial Pain/etiology , Facial Pain/therapy , Fatigue/etiology , Fatigue/prevention & control , Humans , Laryngeal Cartilages/pathology , Mouth Mucosa/pathology , Mucositis/etiology , Mucositis/prevention & control , Nausea/etiology , Nausea/prevention & control , Necrosis/etiology , Necrosis/therapy , Periodontal Diseases/etiology , Periodontal Diseases/prevention & control , Radiodermatitis/etiology , Radiodermatitis/prevention & control , Vomiting/etiology , Vomiting/prevention & control , Weight Loss , Xerostomia/etiology , Xerostomia/prevention & control
3.
J Int Adv Otol ; 16(1): 141-144, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32209522

ABSTRACT

Preservation of the chorda tympani is important in middle ear surgery to prevent dysgeusia postoperatively. However, determining the exact course of the chorda tympani before surgery is not always possible, especially in cases with accompanying malformations. In this report, we presented an extremely rare case of bifurcation of the chorda tympani in a 15-year-old male patient. We performed tympanoplasty for a middle ear malformation with conductive hearing loss. During the operation, we noticed and carefully preserved the bifurcated chorda tympani. The patient did not develop dysgeusia postoperatively. Appropriate handling and understanding of the anomalous chorda tympani preserved the patient's sense of taste and hence quality of life.


Subject(s)
Chorda Tympani Nerve/abnormalities , Chorda Tympani Nerve/surgery , Ear, Middle/innervation , Adolescent , Dysgeusia/prevention & control , Ear, Middle/abnormalities , Ear, Middle/diagnostic imaging , Ear, Middle/surgery , Hearing Loss, Conductive/etiology , Hearing Loss, Conductive/surgery , Humans , Male , Otologic Surgical Procedures/statistics & numerical data , Postoperative Period , Quality of Life , Tomography, X-Ray Computed/methods , Treatment Outcome , Tympanoplasty/methods
4.
Cancer Radiother ; 23(5): 439-448, 2019 Sep.
Article in French | MEDLINE | ID: mdl-31358445

ABSTRACT

Intensity-modulated radiation therapy (IMRT) is presently the recommended technique for the treatment of locally advanced head and neck carcinomas. Proton therapy would allow to reduce the volume of irradiated normal tissue and, thus, to decrease the risk of late dysphagia, xerostomia, dysgeusia and hypothyroidism. An exhaustive research was performed with the search engine PubMed by focusing on the papers about the physical difficulties that slow down use of proton therapy for head and neck carcinomas. Range uncertainties in proton therapy (±3 %) paradoxically limit the use of the steep dose gradient in distality. Calibration uncertainties can be important in the treatment of head and neck cancer in the presence of materials of uncertain stoichiometric composition (such as with metal implants, dental filling, etc.) and complex heterogeneities. Dental management for example may be different with IMRT or proton therapy. Some uncertainties can be somewhat minimized at the time of optimization. Inter- and intrafractional variations and uncertainties in Hounsfield units/stopping power can be integrated in a robust optimization process. Additional changes in patient's anatomy (tumour shrinkage, changes in skin folds in the beam patch, large weight loss or gain) require rescanning. Dosimetric and small clinical studies comparing photon and proton therapy have well shown the interest of proton therapy for head and neck cancers. Intensity-modulated proton therapy is a promising treatment as it can reduce the substantial toxicity burden of patients with head and neck squamous cell carcinoma compared to IMRT. Robust optimization will allow to perform an optimal treatment and to use proton therapy in current clinical practice.


Subject(s)
Head and Neck Neoplasms/radiotherapy , Health Physics , Proton Therapy , Radiation Injuries/prevention & control , Radiation Oncology , Squamous Cell Carcinoma of Head and Neck/radiotherapy , Translational Research, Biomedical , Deglutition Disorders/etiology , Deglutition Disorders/prevention & control , Dysgeusia/etiology , Dysgeusia/prevention & control , Humans , Hypothyroidism/etiology , Hypothyroidism/prevention & control , Models, Theoretical , Organs at Risk , Radiation Injuries/etiology , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted , Radiotherapy, Image-Guided , Radiotherapy, Intensity-Modulated/adverse effects , Uncertainty , Xerostomia/etiology , Xerostomia/prevention & control
5.
Med Oncol ; 36(5): 44, 2019 Apr 09.
Article in English | MEDLINE | ID: mdl-30968205

ABSTRACT

Dysgeusia and nausea are common side effects observed in head and neck cancer patients treated with either exclusive radiotherapy or combined modality treatment. The aim of the present study was to prospectively evaluate dysgeusia, during treatment and follow-up, using the chemotherapy-induced taste alteration scale (CiTAS), a metrics based on 18-items exploring three dimensions (quantitative and qualitative changes in taste perception, and diet-related issues) identified through a four-factor analysis: decline in basic taste, discomfort, phantogeusia-parageusia, and general taste alterations. Moreover, we scored, according to Common Toxicity Criteria Adverse Events, nausea and other treatment-related toxicities. Since, ginger is traditionally used to prevent and/or treat nausea and vomiting, we prophylactically employed a ginger-based supplement named Naumix/Naugin (Gamfarma, Milan, Italy), to potentially mitigate both nausea and taste impairment. Using the CiTAS scale, we highlighted a progressive increase in all dysgeusia dimensions, peaking at the VII week of treatment and a subsequent partial late recovery. In particular, we observed a recovery for discomfort, phantogeusia-parageusia, and general taste alterations at 6 months. Grade 2 nausea, observed to be as low as 12.9% potentially due to the use of ginger, peaked at the III week of treatment. Finally, for patients experiencing nausea, the dysgeusia dimension of discomfort was also relevant.


Subject(s)
Dysgeusia/etiology , Head and Neck Neoplasms/complications , Head and Neck Neoplasms/radiotherapy , Nausea/etiology , Taste/radiation effects , Adult , Aged , Aged, 80 and over , Antiemetics/therapeutic use , Disease Progression , Dysgeusia/diagnosis , Dysgeusia/pathology , Dysgeusia/prevention & control , Female , Zingiber officinale , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/pathology , Humans , Male , Middle Aged , Nausea/diagnosis , Nausea/pathology , Nausea/prevention & control , Prospective Studies , Radiotherapy/adverse effects , Severity of Illness Index
6.
Am J Hosp Palliat Care ; 36(9): 815-819, 2019 Sep.
Article in English | MEDLINE | ID: mdl-30754984

ABSTRACT

BACKGROUND: Oral problems are frequent in palliative care and can cause disabling symptoms such as orofacial pain, dysgeusia, and xerostomia. Even if oral care is an essential aspect of nursing, it is often not considered as a priority, especially when various complex patients' needs have to be managed. OBJECTIVE: The aim of this study was to describe oral conditions and evaluate the impact of standard oral care on symptom control and patient's perceived comfort in a sample of terminally ill patients. METHOD: A prospective cohort study was carried out among 415 patients who were admitted to hospice. Patients were recruited before undergoing standard assisted procedure for oral hygiene care. Oral cavity condition, symptoms, and comfort were assessed at the recruitment (T0) and after 3 days (T2). RESULTS: Seventy-five eligible patients were recruited. The Oral Assessment Guide score was significantly decreased after oral standard care (P value <.0001). The average time spent by nursing staff for oral hygiene care was 5.3 minutes. Dysgeusia and xerostomia were significantly decreased after oral standard care (P = .02 and P = .03). Patients reported a high level of comfort (86.6%) after the procedures for oral hygiene care. CONCLUSION: Patients admitted to hospice had frequent alterations in oral cavity with partial loss of its functions that can compromise their quality of life. Standard procedures for oral hygiene care are simple and fast to perform, and they may improve oral cavity conditions, symptoms control, and patients' comfort.


Subject(s)
Hospice Care/organization & administration , Oral Hygiene/nursing , Aged , Aged, 80 and over , Dysgeusia/prevention & control , Female , Humans , Male , Middle Aged , Mouth Diseases/prevention & control , Palliative Care/organization & administration , Prospective Studies , Quality of Life , Time Factors
7.
Laryngoscope ; 128(8): 1904-1913, 2018 08.
Article in English | MEDLINE | ID: mdl-29086423

ABSTRACT

OBJECTIVE: The objective of our systematic review is to investigate the postoperative gustatory function of the chorda tympani nerve following noninflammatory ear surgery for which the chorda tympani is at risk for iatrogenic injury (stretching, handling, or sacrificing). DATA SOURCES: PubMed and EMBASE. REVIEW METHODS: A PubMed and EMBASE databases search was conducted on November 15, 2016. Study inclusion criteria included: 1) ear surgery performed for noninflammatory ear diseases, and 2) gustatory function of the chorda tympani reported as an outcome. The quality of eligible studies was assessed using the risk of bias assessment tool for nonrandomized studies. Study characteristics and outcome data of the included studies were extracted. RESULTS: In total 1,094 articles were retrieved. Fourteen studies encompassing 1,062 operated ears were included after quality assessment. Stapedectomy was the most frequent surgical procedure performed in 398 ears. The follow-up time varied between 6 weeks and 99 months. Patients with a preserved chorda tympani were less symptomatic (24% was symptomatic) compared to patients with a stretched (53% was symptomatic) or sacrificed chorda tympani (47% was symptomatic). The recovery rate varied from 61% to 79%. The results of the electrogustometry and strip test showed a discrepancy with the subjective complaints of the patients. CONCLUSION: Patients with a stretched chorda tympani were slightly more symptomatic compared to patients with a sacrificed chorda tympani. Therefore, in cases for which the chorda tympani greatly hinders a proper view of the surgical field, sacrificing the nerve could be considered to maximize surgical performance and have a satisfactory postoperative result. Laryngoscope, 1904-1913, 2018.


Subject(s)
Chorda Tympani Nerve/injuries , Dysgeusia/etiology , Ear Diseases/surgery , Otologic Surgical Procedures/adverse effects , Dysgeusia/prevention & control , Humans , Iatrogenic Disease/prevention & control , Recovery of Function
8.
Support Care Cancer ; 24(9): 3979-85, 2016 09.
Article in English | MEDLINE | ID: mdl-27129837

ABSTRACT

PURPOSE: Dysgeusia is one of the sporadic adverse effects induced by chemotherapy, but it remains poorly understood. The aim of this study was to retrospectively identify the risk factors related with dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation (AHSCT). METHODS: Forty-eight patients with myeloma or lymphoma undergoing AHSCT were enrolled in this study. Data regarding dysgeusia and symptoms were collected by interviews conducted by medical workers. Patient characteristics and unfavorable effects induced by dysgeusia were obtained from medical records and analyzed. Logistic regression analysis was performed to identify the risk factors related with dysgeusia. RESULTS: Of the 48 patients, 20 (42 %) had dysgeusia after AHSCT. The total period of parenteral nutrition (TPN) administration and period of decreased oral intake in the dysgeusia group were statistically longer than those in the non-dysgeusia group. Multivariate analyses revealed that oral mucositis (odds ratio: 30.3; p < 0.01) and the type of chemotherapy prior to AHSCT (odds ratio: 6.56; p < 0.05) were independent risk factors, while oral cryotherapy was the independent suppressive factor of dysgeusia (odds ratio: 0.14; p < 0.05). CONCLUSION: Our study showed that dysgeusia after AHSCT led to the decrease in oral intake and extended the TPN administration period. Moreover, MEAM or LEED chemotherapy and oral mucositis were independent risk factors for dysgeusia in patients undergoing AHSCT, while oral cryotherapy was an independent suppressive factor for dysgeusia. Therefore, oral cryotherapy should be implemented into the regimen of supportive care management in patients undergoing AHSCT.


Subject(s)
Antineoplastic Agents/adverse effects , Cryotherapy/methods , Dysgeusia/chemically induced , Dysgeusia/prevention & control , Hematopoietic Stem Cell Transplantation/adverse effects , Adult , Aged , Antineoplastic Agents/administration & dosage , Female , Hematopoietic Stem Cell Transplantation/methods , Humans , Lymphoma/drug therapy , Lymphoma/therapy , Male , Melanoma/drug therapy , Melanoma/therapy , Middle Aged , Retrospective Studies , Risk Factors , Transplantation Conditioning/adverse effects , Transplantation Conditioning/methods , Transplantation, Autologous
10.
Appetite ; 83: 178-184, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25173061

ABSTRACT

Voluntary running in an activity wheel establishes aversion to paired taste in rats. A proposed mechanism underlying this taste aversion learning is gastrointestinal discomfort caused by running. We tested this hypothesis by measuring the pica behavior (kaolin clay intake) of rats, because it is known that rats engage in pica behavior after various nausea-inducing treatments including irradiation, motion sickness, and injection of emetic drugs such as lithium chloride (LiCl). Following a demonstration of the already-known phenomenon of LiCl-based pica in Experiment 1, we successfully showed running-based pica behavior in Experiment 2 where the running treatment was compared with a non-running control treatment (i.e., confinement in a locked wheel). These results suggest that not only LiCl but also running induces nausea in rats, supporting the gastrointestinal discomfort hypothesis of running-based taste aversion learning.


Subject(s)
Abdominal Pain/physiopathology , Avoidance Learning , Disease Models, Animal , Dysgeusia/etiology , Models, Biological , Pica/etiology , Stress, Physiological , Abdominal Pain/chemically induced , Abdominal Pain/etiology , Abdominal Pain/prevention & control , Aluminum Silicates/administration & dosage , Animals , Behavior, Animal , Clay , Dysgeusia/chemically induced , Dysgeusia/physiopathology , Dysgeusia/prevention & control , Emetics/administration & dosage , Emetics/toxicity , Injections, Intraperitoneal , Kaolin/administration & dosage , Lithium Chloride/administration & dosage , Lithium Chloride/toxicity , Male , Motor Activity , Nausea/chemically induced , Nausea/etiology , Nausea/physiopathology , Nausea/prevention & control , Physical Exertion , Rats, Wistar
11.
Med Clin (Barc) ; 141(2): 77-81, 2013 Jul 21.
Article in Spanish | MEDLINE | ID: mdl-23664688
12.
Eur J Oncol Nurs ; 14(4): 291-8, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20584624

ABSTRACT

PURPOSE: This study seeks to establish causal models of diet which maintain the appetite of head and neck cancer patients receiving radiation therapy. SAMPLE AND METHODS: We collected data from 208 patients at two radiation doses, 30/50 Gy, using a questionnaire on appetite and analyzed the items using structural equation modeling. RESULTS: In the causal model for 30 Gy, we established a path using the four intervening variables "ease of consuming foods in smooth forms," "ease of consuming foods with a chewable texture and suitable temperature," "ease of consuming lightly seasoned foods with a flavorful smell," and "overall ease of consuming a given meal" from the temporal relationship between "dietary preferences" and "maintaining appetite while caring for the oral cavity." In the causal model for 50 Gy, we established a path between "ease of consuming foods with a mild temperature and smell," and "maintaining appetite while caring for the oral cavity" using the four intervening variables "ease of consuming foods that are easy to swallow," "ease of consuming foods that dissolve well in the mouth," "ease of consuming foods with a mild taste," and "overall ease of consuming a given meal." The goodness of fit indices for both models were above 0.85 for both the goodness of fit index (GFI) and adjusted GFI (AGFI), and less than 0.08 for root mean square error of approximation (RMSEA), indicating a satisfactory goodness of fit. CONCLUSIONS: Food characteristics help to maintain patient appetite at cumulative radiation doses of 30/50 Gy.


Subject(s)
Appetite , Attitude to Health , Food Preferences/psychology , Head and Neck Neoplasms/radiotherapy , Models, Psychological , Aged , Aged, 80 and over , Anorexia/etiology , Anorexia/prevention & control , Dysgeusia/etiology , Dysgeusia/prevention & control , Factor Analysis, Statistical , Female , Head and Neck Neoplasms/complications , Head and Neck Neoplasms/psychology , Humans , Japan , Male , Menu Planning , Middle Aged , Motivation , Nursing Methodology Research , Radiotherapy Dosage , Regression Analysis , Stomatitis/etiology , Stomatitis/prevention & control , Surveys and Questionnaires , Xerostomia/etiology , Xerostomia/prevention & control
14.
Crit Rev Oral Biol Med ; 14(3): 213-25, 2003.
Article in English | MEDLINE | ID: mdl-12799324

ABSTRACT

The location of the primary tumor or lymph node metastases dictates the inclusion of the oral cavity, salivary glands, and jaws in the radiation treatment portals for patients who have head and neck cancer. The clinical sequelae of the radiation treatment include mucositis, hyposalivation, loss of taste, osteoradionecrosis, radiation caries, and trismus. These sequelae may be dose-limiting and have a tremendous effect on the patient's quality of life. Most treatment protocols to prevent these sequelae are still based on clinical experience, but alternatives based on fundamental basic and clinical research are becoming more and more available. Many of these alternatives either need further study before they can be incorporated into the protocols commonly used to prevent and treat the radiation-related oral sequelae or await implementation of these protocols. In this review, the various possibilities for prevention and/or treatment of radiation-induced changes in healthy oral tissues and their consequences are discussed.


Subject(s)
Cranial Irradiation/adverse effects , Jaw Diseases/prevention & control , Mouth Diseases/prevention & control , Osteoradionecrosis/prevention & control , Stomatitis/prevention & control , Anti-Bacterial Agents/therapeutic use , Dental Caries/etiology , Dental Caries/prevention & control , Dysgeusia/etiology , Dysgeusia/prevention & control , Head and Neck Neoplasms/radiotherapy , Humans , Jaw Diseases/etiology , Mouth Diseases/etiology , Mouth Mucosa/radiation effects , Muscarinic Agonists/therapeutic use , Osteoradionecrosis/etiology , Pilocarpine/therapeutic use , Stomatitis/etiology , Trismus/etiology , Trismus/prevention & control , Xerostomia/etiology , Xerostomia/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL